Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for reducing blood loss during caesarean section
PACTR202107872851363Completed
- Sponsor
- Kelvin Ortuanya
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Kelvin Ortuanya. Primary endpoints: Mean intra-operative blood loss during caesarean delivery and Hematocrit change 48 hours postoperatively. Started Jul 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202107872851363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202107872851363.